Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis.

about

Combined use of warfarin and oral P2Y12 inhibitors in patients with atrial fibrillation and acute coronary syndrome.

P2860

Q53655058-24E06453-F984-4F69-AE57-9D3F3FF2E95C

P2860

Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis.

Item

http://www.wikidata.org/entity/Q36411732

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Triple antithrombotic therapy ...... events, and stent thrombosis.

@ast

Triple antithrombotic therapy ...... events, and stent thrombosis.

@en

type

Item

label

Triple antithrombotic therapy ...... events, and stent thrombosis.

@ast

Triple antithrombotic therapy ...... events, and stent thrombosis.

@en

prefLabel

Triple antithrombotic therapy ...... events, and stent thrombosis.

@ast

Triple antithrombotic therapy ...... events, and stent thrombosis.

@en

P1476

Triple antithrombotic therapy ...... events, and stent thrombosis.

@en

P2093

Andrea Rubboli

http://www.w3.org/2001/XMLSchema#string

Antonio Manari

http://www.w3.org/2001/XMLSchema#string

Mila Menozzi

http://www.w3.org/2001/XMLSchema#string

Roberto Grilli

http://www.w3.org/2001/XMLSchema#string

Rossana De Palma

http://www.w3.org/2001/XMLSchema#string

P2860

Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation

Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting

Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline

Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?

Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding

Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting

Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention

Periprocedural and medium-term antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary angiography and intervention

P2888

1477-9560-10-22

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-9560-10-22

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232279708

http://www.w3.org/2001/XMLSchema#string

P6179

1046658093

http://www.w3.org/2001/XMLSchema#string

P698

23075316

http://www.w3.org/2001/XMLSchema#string

P921

thrombosis

thromboembolism

P932

3502192

http://www.w3.org/2001/XMLSchema#string

Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis.

about

P2860

P2860

Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921

P932